US Broker Ratings

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 24.77% Potential Upside Amid Strong Buy Ratings

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, is capturing investor attention with a promising 24.77% potential upside according to recent analyst ratings. As a key player..

Insmed Incorporated (INSM) Stock Analysis: Potential 37% Upside Amid Robust Revenue Growth

Investors are closely eyeing Insmed Incorporated (NASDAQ: INSM) as this biotechnology company continues to make strides in developing therapies for serious and rare diseases. With a market capitalization of $33.32..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 10.61% Potential Upside Amidst Strategic Healthcare Innovations

Investors eyeing the healthcare sector may find Koninklijke Philips N.V. (NYSE: PHG) an intriguing option, particularly with its potential upside of 10.61% based on current analyst targets. As a cornerstone..

Fresenius Medical Care AG (FMS) Investor Outlook: A 30% Upside Potential Amidst Industry Challenges

Fresenius Medical Care AG (FMS), a prominent player in the healthcare sector, is at the forefront of medical care facilities, specializing in dialysis and related services. As it navigates the..

ResMed Inc. (RMD) Stock Analysis: Unraveling a 15.83% Potential Upside in Healthcare Innovation

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, presents a compelling opportunity for investors. With a robust market capitalization..

Natera, Inc. (NTRA) Stock Analysis: Exploring a 6.47% Potential Upside Amid Strong Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a leader in the diagnostics and research industry, has been making waves in the healthcare sector with its advanced molecular testing services. With a market cap..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a Promising 1.79% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor interest, combining a robust market presence with steady growth potential. With a towering market capitalization..

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its 11.98% Potential Upside

Biogen Inc. (BIIB), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, has drawn investor interest with its expansive portfolio of therapies targeting neurological and neurodegenerative..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 9.34% Potential Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. The London-based company, with..

Merck & Co. (MRK) Stock Analysis: Exploring Growth Potential and Strong Analyst Sentiment

Merck & Company, Inc. (NYSE: MRK), a global leader in the healthcare sector, continues to capture investor attention thanks to its robust pipeline, strategic partnerships, and favorable analyst ratings. With..

Insulet Corporation (PODD) Stock Analysis: 37.68% Potential Upside Amid Strong Revenue Growth

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, particularly in medical devices, is making waves with its innovative insulin delivery systems. With a substantial market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 42% Upside Potential with Robust Analyst Ratings

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector with its specialized focus on post-acute healthcare services. Based out of Birmingham, Alabama, Encompass Health operates extensive inpatient rehabilitation..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Valuation Challenges Amidst Growth Opportunities

Illumina, Inc. (NASDAQ: ILMN), a pivotal player in the diagnostics and research industry, continues to command attention from investors due to its cutting-edge genetic and genomic analysis solutions. As a..

Hologic, Inc. (HOLX) Stock Analysis: Exploring Growth Potential Amidst a Healthcare Innovation Drive

Hologic, Inc. (NASDAQ: HOLX), a pivotal player in the healthcare sector, specializes in medical instruments and supplies, primarily focusing on women’s health. With a market capitalization of $16.75 billion, Hologic..

Pfizer, Inc. (PFE) Stock Analysis: Navigating the 6.71% Dividend Yield Amidst Market Volatility

Pfizer Inc. (NYSE: PFE), a titan in the healthcare sector, stands as a beacon of innovation and resilience in the drug manufacturing industry. Headquartered in New York, Pfizer’s operations span..

Baxter International Inc. (BAX) Stock Analysis: Navigating Growth with a 16.60% Potential Upside

Baxter International Inc. (NYSE: BAX) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With its headquarters in Deerfield, Illinois, and a market capitalization of..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Global Presence

Incyte Corporation (NASDAQ: INCY) stands as a formidable player in the biotechnology sector, boasting a market capitalization of $20.02 billion. This Delaware-based biopharmaceutical company is renowned for its commitment to..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating the 4.61% Dividend Yield and Growth Outlook

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the global pharmaceutical industry, continues to capture investor interest with its robust dividend yield and strategic growth in biopharmaceuticals. With a market..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring the 15.33% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC), a stalwart in the medical devices sector, is capturing investor attention with its compelling growth prospects and strategic positioning in the healthcare industry. With..

Quest Diagnostics (DGX) Investor Outlook: Navigating a 9.59% Potential Upside in the Healthcare Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare diagnostics and research industry, is poised to attract investor attention with its potential upside of 9.59%, based on the average..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds